CRB-913
CANYON-1
Corbus Pharmaceuticals · Phase 1 · Completed · Enrollment 254
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| Part 1: PK Lead-in | n/r | n/r | n/r | n/r | n/r |
| Part 2: CRB-913 low dose | n/r | n/r | n/r | n/r | n/r |
| Part 2: CRB-913 Medium Dose | n/r | n/r | n/r | n/r | n/r |
| Part 2: CRB-913 High Dose | n/r | n/r | n/r | n/r | n/r |
| Part 2: Placebo | n/r | n/r | n/r | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.